heart drug - International Biopharmaceutical Industry

Current Edition

news

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Leqvio arrives with high sales expectations, but uptake could be slow as insurers and doctors weigh the drug's safety and cost-effectiveness. Novartis on Wednesday w...

7 January 2022 news FDA | genetic drug

Continue Reading →

news

Novartis finalizes deal to make new heart drug widely available in England

Novartis has made a big bet on Leqvio and now the U.K. government has, too, motivated by the prevalence of heart disease and its strong links to high cholesterol. Leq...

3 September 2021 news England | heart disease

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Novartis finalizes deal to make new heart drug widely available in England

International Biopharmaceutical Industry